Company Overview of 3-V Biosciences, Inc.
3-V Biosciences, Inc. operates as a biopharmaceutical company that discovers and develops therapeutics for the treatment of oncology and infectious diseases. The company offers a TVB-2640, a fatty acid synthase inhibitor that blocks tumor cell signaling pathways and induces tumor cell apoptosis. It also focuses on developing antiviral therapeutic candidates for respiratory syncytial virus, cytomegalovirus, and other human pathogens. The company was incorporated in 2006 and is based in Menlo Park, California.
1050 Hamilton Court
Menlo Park, CA 94025
Founded in 2006
Key Executives for 3-V Biosciences, Inc.
3-V Biosciences, Inc. Key Developments
Similar Private Companies By Industry
|Percipio Biotherapeutics, Inc.||United States|
|OrPro Therapeutics, Inc.||United States|
|Pure Cultures LLC||United States|
|Xsira Pharmaceuticals, Inc.||United States|
|OrphoMed, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Only a company representative may request an update for the company profile. Documentation will be required.
To contact 3-V Biosciences, Inc., please visit www.3vbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.